Fresenius QCDC-Weymouth (#9144) — Weymouth, Massachusetts

Fresenius QCDC-Weymouth (#9144) is a clinical research site located in Weymouth, Massachusetts, United States 02190.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

Fresenius QCDC-Weymouth (#9144) has participated in 1 clinical trials.

Therapeutic areas: Dialysis, Cardiovascular Disease, Atherosclerosis.

Sponsors: Brigham and Women's Hospital.

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Fresenius QCDC-Weymouth (#9144)?

Fresenius QCDC-Weymouth (#9144) has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Fresenius QCDC-Weymouth (#9144) conducted?

Fresenius QCDC-Weymouth (#9144) has 1 clinical trials on record. Their work covers Dialysis, Cardiovascular Disease, Atherosclerosis.

Is Fresenius QCDC-Weymouth (#9144) accredited by Crixeo Health?

Fresenius QCDC-Weymouth (#9144) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Fresenius QCDC-Weymouth (#9144)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.